Why Sanmina (SANM) is a Top Growth Stock for the Long-Term

Sanmina is rated Zacks Rank #1 (Strong Buy), with a B Growth Score and B VGM Score, supported by projected fiscal-year earnings growth of 100.5%. Four analysts raised fiscal 2026 estimates over the past 60 days, lifting the consensus EPS forecast by $0.89 to $12.11; the company has delivered an average earnings surprise of 16.7%. The article presents a favorable analyst-driven growth case for the electronics manufacturing and supply-chain provider, including exposure to cloud and AI infrastructure.

Analysis

The estimate-reset signal is potentially meaningful, but the implied earnings step-up requires decomposition before underwriting a durable growth multiple. For an electronics manufacturer, a large EPS revision can reflect mix improvement, operating leverage, tax/one-time items, or a reduced share count rather than a proportional increase in end-market demand. The investable question for the next 1-3 months is whether revenue and gross-margin guidance rise alongside EPS; without both, the stock is vulnerable to a post-earnings "quality of beat" selloff despite favorable momentum.

SANM's differentiated exposure is higher-complexity, regulated production, where qualification cycles and switching costs can support better margins than commodity EMS peers such as FLEX, JABIL, and CLS. If AI/networking and defense programs are driving the revision cycle, SANM could earn incremental multiple expansion over 6-18 months because these programs improve factory utilization and customer stickiness. Conversely, an industrial or communications inventory correction would hit utilization disproportionately, making margin gains reverse faster than revenue.

Consensus may be treating the revision as a generic AI-manufacturing read-through. The more contrarian interpretation is that the addressable upside is specific to program ramps and therefore lumpy; elevated expectations leave little tolerance for a one-quarter timing slip. NNOX has no fundamental linkage to this setup; its inclusion appears promotional and should not be used as a semiconductor-manufacturing or healthcare-equipment read-through.

Key Decisions for Investors

• Initiate a small long SANM only on confirmation that the next report raises revenue guidance and sustains gross margin; target a 10-15% move over 1-3 months from further estimate revisions, with a 5-7% stop if guidance is maintained rather than raised.
• Express relative strength via long SANM / short FLEX in equal dollar amounts over 3-6 months if SANM demonstrates higher-margin defense, medical, or infrastructure mix; exit if SANM's gross-margin premium fails to widen or FLEX receives a comparable earnings revision cycle.
• Do not chase a pre-results momentum move without backlog, program-ramp, and free-cash-flow conversion data. Set an alert for downward revisions to fiscal EPS or a sequential decline in utilization-related margin commentary; either would falsify the operating-leverage thesis.
• Avoid using NNOX as a sympathy position. Its risk/reward is driven by imaging-system adoption, reimbursement, and financing—not electronics manufacturing demand—and this item supplies no incremental evidence on those variables.